Non-interventional Study on Long-term Application of Galantamine and Nootropics in Patients With Alzheimer's Disease.

Trial Profile

Non-interventional Study on Long-term Application of Galantamine and Nootropics in Patients With Alzheimer's Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2014

At a glance

  • Drugs Galantamine; Ginkgo biloba; Nicergoline; Nootropics; Piracetam
  • Indications Alzheimer's disease; Vascular dementia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 15 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top